Aug. 25 at 11:29 AM
$IMRX Summary of Immuneering Corporation's Form 8-K Filing (Item 1.01) On August 21, 2025, Immuneering Corporation entered into a Securities Purchase Agreement with investors for a private placement, raising approximately
$25 million in gross proceeds (before expenses). The transaction involves: Securities Issued: 6,329,113 shares of Class A common stock (par value
$0.001) or, for certain investors, pre-funded warrants (exercise price
$0.001 per share) in lieu of shares.
Accompanying purchase warrants to buy up to 2,848,096 shares (exercise price
$5.50 per share).
Each share (or pre-funded warrant) includes a purchase warrant for 45% of one share, with a combined purchase price of
$3.95 per unit (less pre-funded warrant exercise price, if applicable).
Key Warrant Terms: Pre-funded warrants: Immediately exercisable until fully exercised, with cashless exercise option. (continued below)
